T. Rowe Price Associates’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,599
| Closed | -$189K | – | 3010 |
|
|
2023
Q4 | $189K | Sell |
74,599
-8,367
| -10% | -$21.2K | ﹤0.01% | 2559 |
|
|
2023
Q3 | $199K | Buy |
82,966
+3,681
| +5% | +$8.83K | ﹤0.01% | 2503 |
|
|
2023
Q2 | $184K | Buy |
79,285
+1,362
| +2% | +$3.16K | ﹤0.01% | 2555 |
|
|
2023
Q1 | $199K | Buy |
77,923
+3,782
| +5% | +$9.66K | ﹤0.01% | 2532 |
|
|
2022
Q4 | $186K | Buy |
74,141
+14,237
| +24% | +$35.7K | ﹤0.01% | 2552 |
|
|
2022
Q3 | $174K | Sell |
59,904
-4,209,521
| -99% | -$12.2M | ﹤0.01% | 2590 |
|
|
2022
Q2 | $19.3M | Sell |
4,269,425
-1,567,589
| -27% | -$7.09M | ﹤0.01% | 1173 |
|
|
2022
Q1 | $46.8M | Buy |
5,837,014
+1,118,293
| +24% | +$8.97M | ﹤0.01% | 988 |
|
|
2021
Q4 | $54.9M | Buy |
4,718,721
+2,903,722
| +160% | +$33.8M | ﹤0.01% | 971 |
|
|
2021
Q3 | $22.5M | Buy |
+1,814,999
| New | +$22.5M | ﹤0.01% | 1263 |
|